During the last session, Processa Pharmaceuticals Inc (NASDAQ:PCSA)’s traded shares were 1.89 million, with the beta value of the company hitting 1.33. At the end
In the last trading session, 2.39 million shares of the Processa Pharmaceuticals Inc (NASDAQ:PCSA) were traded, and its beta was 1.33. Most recently the company’s
In the last trading session, 0.81 million shares of the Processa Pharmaceuticals Inc (NASDAQ:PCSA) were traded, and its beta was 1.33. Most recently the company’s
Processa Pharmaceuticals Inc (NASDAQ:PCSA)’s traded shares stood at 9.21 million during the last session, with the company’s beta value hitting 1.37. At the close of
Processa Pharmaceuticals Inc (NASDAQ:PCSA) has a beta value of 1.41 and has seen 1.26 million shares traded in the last trading session. The company, currently
Processa Pharmaceuticals Inc (NASDAQ:PCSA)’s traded shares stood at 1.55 million during the last session, with the company’s beta value hitting 1.37. At the close of
In the last trading session, 1.29 million Processa Pharmaceuticals Inc (NASDAQ:PCSA) shares changed hands as the company’s beta touched 1.23. With the company’s per share
In the last trading session, 2.05 million Processa Pharmaceuticals Inc (NASDAQ:PCSA) shares changed hands as the company’s beta touched 1.33. With the company’s per share
In last trading session, Processa Pharmaceuticals Inc (NASDAQ:PCSA) saw 50.61 million shares changing hands with its beta currently measuring 1.31. Company’s recent per share price
Processa Pharmaceuticals Inc (NASDAQ:PCSA) has a beta value of 1.31 and has seen 44.44 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
